ALB and neoplasm: Therefore, inflammation-based biomarkers such as C-reactive protein albumin ratio (CAR), platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), and albumin-globulin ratio (AGR) have been used for early assessment of prognosis in a variety of tumours (8, 9).